Avista Healthcare
Departing Nycomed CEO Bolsters Leading Private Equity Healthcare Practice New York, NY, October 3, 2011 – Avista Capital Partners, a leading private equity firm, today announced that it has hired Håkan Björklund, the departing Chief Executive Officer of Nycomed, as Healthcare Operating Executive. Mr. Björklund worked closely with Avista on the development of Nycomed during […]
OSAKA, Japan, September 30, 2011 – Takeda Pharmaceutical Company Limited (“Takeda”, TSE: 4502) announced it has completed its acquisition of Nycomed A/S (“Nycomed”) for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day. Dr. Frank Morich has been named CEO of Nycomed in […]
Skillman, NJ, September 1, 2011 – ConvaTec Inc., a world-leading developer and marketer of innovative medical technologies for community and hospital care today announced that the company has acquired Boston Medical Device, Inc. (BMD), a distribution company that offers a platform of specialized medical devices throughout Latin America. More than 30 years of management experience […]
by John George Philadelphia Business Journal Yardley, PA, June 3, 2011 – Peter Miller was sniffing around for his next entrepreneurial opportunity last summer when he decided to join OptiNose as CEO of the Bucks County company that has developed a new way to deliver medicine. “I fell in love with two things,” said Miller, […]
OSAKA, Japan, and ZURICH, Switzerland, May 19, 2011 – Takeda Pharmaceutical Company Limited (“Takeda”, TSE: 4502) and Nycomed A/S (“Nycomed”) jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for 9.6 billion Euro on a cash-free, debt-free basis. The boards of directors […]
Cincinnati, OH and Raleigh, N.C., May 4, 2011 – INC Research, LLC, a therapeutically focused global contract research organization (CRO) privately held by Avista Capital Partners and Ontario Teachers’ Pension Plan, and Kendle International Inc. (Nasdaq: KNDL), today jointly announced a definitive merger agreement under which INC Research will acquire Kendle in an all-cash transaction […]
Results Further Demonstrate Efficacy Potential of OptiNose Technology Across Multiple Conditions Yardley, PA, October 20, 2010 – Today OptiNose Inc. announced the positive results of a study evaluating the efficacy of fluticasone when delivered by the Company’s novel bi-directional technology in patients with refractory chronic rhinosinusitis (CRS). The results of the study have been published […]
New York, NY, August 19, 2010 – Avista Capital Partners, a leading private equity firm, and Ontario Teachers’ Pension Plan, through its private investor department, Teachers’ Private Capital, announced today that they have signed an agreement to acquire INC Research, Inc. from an investor group led by Crosspoint® Venture Partners and Adams Street Partners. INC […]
New York, NY, June 7, 2010 – Avista Capital Partners (“Avista”), a leading private equity firm, today announced it has committed to invest $48.5 million in OptiNose (“OptiNose” or “the Company”). OptiNose has developed an innovative nasal drug delivery technology that enables administration of drugs deep in the nasal cavity, enabling the treatment of both […]
Lake Forest, IL, Nov. 30, 2009 – Stericycle, Inc. (NASDAQ:SRCL), today announced that it has entered into an agreement with the United States Department of Justice and the States of Missouri and Nebraska providing clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 that will allow Stericycle to complete its pending acquisition of MedServe, Inc. […]
Forest Laboratories acquires exclusive commercialisation rights to Daxas® in the United States in treatment of symptomatic COPD Nycomed to receive US$100 million upfront payment plus significant milestones and royalties Daxas filed for approval in US and Europe following encouraging results from four Phase III studies Access to Forest Laboratories’ 2,700-strong US sales force completes global […]
Houston, TX, May 14, 2009 – MedServe, Inc., a private company, today announced that it has entered into an agreement to be acquired by Stericycle, Inc. (Nasdaq: SRCL) for $185 million in cash. MedServe has been majority-owned by Avista Capital Partners, Chrysalis Ventures and Murphree Venture Partners since September 2006. MedServe is engaged in the […]